Search Saint Luke's

Breast Cancer

A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-high or High risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.

Saint Luke’s Cancer Institute genetic counselors help patients assess and manage future cancer risks, especially individuals who may have a hereditary cancer syndrome.

The Cardiology Critical Care rotation involves the provision of pharmaceutical care for those patients in the Coronary Intensive Care Unit (CICU) as well as the Advanced Heart Failure/Heart Transplant Unit (H5 South)

Please fill in the information below to request an appointment with Saint Luke’s Charles & Barbara Duboc Cardio Health & Wellness Center.

A team of cardiologists has used cardiac imaging technology to confirm that cardiovascular disease was a significant issue thousands of years ago.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

Percutaneous coronary intervention is associated with significant short-term improvements in high-risk patients with complex coronary artery disease who are ineligible for coronary artery bypass grafting, according to a new analysis.

Dr. Andrew Sauer wrote an editorial on a newly published study that found more than one in four cardiologists experience mental health conditions.